Viewing Study NCT04844606

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 4:01 PM
Ignite Modification Date: 2026-01-21 @ 7:53 PM
Study NCT ID: NCT04844606
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2021-04-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Sponsor: Eli Lilly and Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ulcerative Colitis View
None Ulcerative Colitis Chronic View
None Inflammatory Bowel Diseases View
None Crohn's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pediatric Ulcerative Colitis View
None Pediatric Crohn's Disease View
None Pediatric UC View
None Pediatric CD View